IL-10-deficient mice develop enterocolitis due to a failure of cytokine regulation; however, the full scope of that response remains poorly defined. Using multiplex analysis to quantify the activity of 23 regulatory and effector cytokines produced by colonic leukocytes, we demonstrate a vast dysregulation process of 18 cytokines in IL-102/2 mice from 7 to 27 weeks of age. Of those, IL-12p40, IL-6, granulocyte macrophage colony-stimulating factor, IFN-g, IL-13 and monocyte chemoattractant protein-1 (MCP-1) had the highest single correlations with pathology (r 5 0.7766-0.7016). Importantly, there were strong associations (r 5 0.7071-0.9074) between those cytokines and as many as 10 additional cytokines, indicating a high degree of cytokine complexity as disease progressed. IL-17 was notable in that it was produced at high levels by colonic leukocytes from IL-102/2 mice with pathology ranging from mild to severe, though it was not produced by healthy IL-102/2 mice lacking pathology. Tumor necrosis factor a (TNFa) by itself displayed only a modest association with pathology (r 5 0.6340), ranking sixth lowest, though it cross-correlated strongly with the synthesis of 12 other cytokines, implying that the destructive effects associated with TNFa may be due to interactions of multiple cytokine activities. IL-23 expression did not correlate with pathology, possibly suggesting that IL-23 is involved in the initiation but not the perpetuation of inflammation. Four cytokines (IL-2, IL-3, IL-4 and IL-5) remained negative in IL-102/2 mice, demonstrating that cytokine dysregulation was not universal. These findings emphasize the need to better understand cytokine networks in chronic inflammation and they provide a rationale for combining immunotherapies in the treatment of intestinal inflammation.
Introduction
IL-10À/À mice develop enterocolitis with high penetrance beginning in young adult animals (1, 2) . Due to the strong immunosuppressive effects of IL-10 (3), the underlying basis for inflammation in IL-10À/À mice results from dysregulation in the balance of local cytokine production. Moreover, disease expression is dependent on the presence of commensal organisms (4) , suggesting that the failure of immune regulation in IL-10À/À mice is derived from an inability to control the host's natural response to antigenic challenge. Immunological features of IL-10À/À mice are typical of a T h 1 process similar to that of Crohn's disease (CD) (1, 3, 5, 6) . Although a number of inflammatory mediators, e.g. IL-1a, IL-6, IL-12, IL-17, IL-23, IFN-c, tumor necrosis factor a (TNFa) and CCL5/regulated on activation normal T cell expressed and secreted (CCL5/RANTES) (6) (7) (8) (9) , have been implicated as contributing to disease in IL-10À/À mice, no studies have yet comprehensively examined the extent of cytokine dysregulation in that animal model. Such information is important for obtaining an integrated understanding of the relationship between local cytokine activity to intestinal pathology, and it will be valuable for designing immunotherapeutic strategies as information from animal models is extended into humans.
Colonic inflammation in IL-10À/À mice can be mediated by either intra-epithelial lymphocytes (IELs) or lamina propria lymphocytes (LPLs) (10) . By adoptive transfer into RAGÀ/À mice, LPL appears to be more effective at inducing colonic pathology; however, that outcome may be artificially influenced by several factors. First, LPLs from IL-10À/À mice may preferentially home to intestinal tissues. Second, LPLs may have a greater proliferative capacity following in vivo transfer. Although both of those would be relevant in adoptive transfer systems, neither precludes the possibility that epithelial leukocytes (even if proliferatively more inert) contribute significantly to the inflammatory process as they naturally exist in situ.
IEL-derived cytokines may be an important part of the host immune response in other ways as well. There is ample evidence demonstrating that cytokines such as IFN-c, TNFa, TGFb, IL-4, IL-15 and IL-17 play a role in either maintaining or disrupting the integrity of the intestinal epithelium during an inflammatory response (11) (12) (13) (14) (15) (16) (17) (18) (19) . Although this may involve cytokines produced by LPLs, the local synthesis of IELderived cytokines also must be considered in that process. Therefore, information about the nature of the cytokine response in the intestinal epithelium is central to many aspects of the local inflammatory response.
In the present study, we were interested in gaining a better understanding of the role of intestinal IELs in the inflammatory response of IL-10À/À mice. To assess that, we have examined the activity of 23 immune response analytes secreted by leukocytes from the colonic epithelium. Because epithelial leukocytes are a heterogeneous population of cells, we refer to them as colonic epithelial leukocytes (CELs) rather than by the common but frequently inappropriate name of IELs, a term that refers only to the lymphocytes. CELs were studied in cohorts of IL-10À/À mice and control animals across a range of ages. Findings from these studies reveal a complex but distinct pattern of cytokine dysregulation beginning as early as 7 weeks of age. Although analyte expression tended to be random as a function of age, most but not all analytes displayed a strong correlation with colonic pathology. Additionally, these studies identify the involvement of analytes previously not associated with colonic pathology in IL-10À/À mice, and they demonstrate that analytes regarded to hold a strong relationship to disease may be of secondary importance.
Methods

Mice
Breeding stocks of homozygous
tm1Cgn /J] on a BALB/cJ background were purchased from the Jackson Laboratories, Bar Harbor, ME, USA; control BALB/c mice were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA). Mice were used in accord with University of Texas Health Science Center institutional animal welfare guidelines.
Histopathological analysis
Mice were euthanized and tissues were recovered from the mid-portion of the proximal and distal colon, fixed in 10% buffered formalin, processed for paraffin embedding and 3-lM tissue sections were stained with hematoxylin and eosin. The degree of inflammation in colon specimens was assessed using a modification of a previously published semi-quantitative grading system (20) . Histopathologic grading consisted of grade 0, no signs of inflammation; grade 1, very low levels of leukocytic infiltration; grade 2, low level of leukocytic infiltration; grade 3, moderate level of leukocytic infiltration; grade 4, high level of leukocytic infiltration, high vascular density and thickening of colon wall and grade 5, transmural leukocytic infiltration, loss of goblet cells, high vascular density and thickening of colon wall. Histopathologic grading was performed in a blinded fashion by a board-certified pathologist with >15 years experience assessing human inflammatory bowel disease.
Leukocyte isolation, multiplex analysis and cell staining CELs were isolated from the colonic tissues using an extraction technique similar to that applied to small intestinal IEL recovery (21) . Numbers of recovered CELs were recorded and the percent purity relative to epithelial cells was determined based on experience in identifying leukocytes in epithelial cell preparations, a process that has been validated by staining with anti-CD45 leukocyte-common antigen to differentiate leukocytes from non-hematopoietic cells. Following isolation, cells were adjusted to a density of 1 3 10 6 ml
À1
and cultured for 24 h at 37°C in a 5% CO 2 environment in serum-free lymphocyte culture medium-3 (Cambrex Bio Science, Walkersville, MD, USA) supplemented with 2-mM L-glutamine and 100 U ml À1 penicillin-streptomycin (Sigma-Aldrich, St Louis, MO, USA). Cell-free supernatants were collected and stored at À80°C until the time of multiplex analysis. Multiplex analysis was done using a mouse cytokine 23-Plex Panel Kit (Bio-Rad, Hercules, CA, USA) with a Bio-Plex 200 System and Bio-Plex Manager Software 4.1. A titration curve was generated from standards provided by the manufacturer, from which the concentration of analyte values was directly determined. Test supernatants from IL-10À/À and control mice were run in duplicate; in general, values between duplicate samples varied by <10%. IL-23p19 activity was measured using a commercial ELISA (e-Bioscience, San Diego, CA, USA).
For flow cytometric analyses, CELs were stained with appropriate combinations of PE-anti-TCRab (H57-597), FITCanti-TCRcd (GL3), FITC-or PE-anti-CD4 (GK1.5), FITC-anti-CD8 (53-6.7), PE-anti-4-1BB (17B5), biotin-anti-OX40 (OX86), biotin-anti-CD69 (H1.2F3), CD16/32 Fc block (2.4G2), streptavidin-PE (BD-PharMingen, San Diego, CA, USA; all reagents), PE-anti-ICOS (7E-17G9) (eBioscience). In total, 1 3 10 6 cells were reacted with 1 lg of Fc block for 10 min at 4°C, followed by 1 lg of primary antibody for 20 min at 4°C. Cells were washed by centrifugation and fixed with 2% formaldehyde or reacted with streptavidin-PE for 15 min at 4°C followed by centrifugation and fixing. Analysis was done on a FACScan instrument using Cell-Quest software (BD Bioscience, San Jose, CA, USA).
Quantitative real-time PCR
Quantitative real-time PCR (Q-real-time PCR) was done using RNA isolated from colonic tissues using an RNAeasy Protect Mini Kit-50, and samples were treated with DNase using an RNase-Free DNase Set-50 (Qiagen, Valencia, CA, USA) according to the manufacturer's protocols. RNA concentrations were estimated electrophotometrically at A 260 . Primer sets for mouse IFN-c (cat. no. PPM03121A; acc. no. NM_008337.1; mRNA reference position 310-331); TNFa (cat. no. PPM03113A; acc. no. NM_013693.1; mRNA reference position 628-648); IL-6 (cat. no. PPM03015A; acc. no. NM_031168.1; mRNA reference position 53-73); IL-23p19 (cat. no. PPM02946E; acc. no. NM_031252.1; mRNA reference position and GAPDH (cat. no. PPM03763E; acc. no. NM_008084.2; mRNA reference position 309-328) were purchased from SuperArray Bioscience Corporation (Frederick, MD, USA). Q-real-time PCR was performed on 100 ng total RNA using an iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad). A blank sample with RNase-free water was used for primer controls. Amplification was done in 96-well thin-wall plates sealed with optical quality film in a Mini-Opticon (Bio-Rad) with a program of 10 min at 50°C for cDNA synthesis, 5 min at 95°C for reverse transcriptase inactivation, followed by 45 cycles of 95°C for 10 s and 55°C for 30 s for data collection. A melt curve was performed using a protocol of 1 min at 95°C and 1 min at 55°C, increasing the temperature in 0.5°C increments for 80 cycles of 10 s each. Real-time PCR data were quantified using the 2
ÀDDCt method of Livak and Schmittgen (22); each sample was normalized to its GAPDH value using a Gene Expression Macro Version 1.1 program (Bio-Rad). In some cases, PCR products were electrophoresed through a 2% agarose gel followed by staining with ethidium bromide.
Statistical analysis
Statistical analyses were performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA). Non-parametric statistics were employed using analyte concentrations as the dependent variable and pathology status as the independent variable, from which the Spearman correlation coefficient was calculated. The Pearson correlation coefficient was used to assess associations between outcome data involving comparisons between analytes. All associations were evaluated on a two-tailed basis. Calculation of statistical analysis comparing pathology scores for all IL-10À/À mice and control mice and pathology scores between male and female IL-10À/À mice was done using Student's t-test for non-paired observations.
Results
Analysis of 23 immune response analytes reveals patterns of cytokine dysregulation
Cohorts of 25 IL-10À/À and six normal BALB/c mice used in this study are shown in Table 1 . IL-10À/À mice represented 10 time points ranging from 7 to 27 weeks of age. Each time point consisted of two to four mice with the exception of a single IL-10À/À mouse used at 18 weeks of age. Control mice ranged from 10 to 52 weeks of age. Sixteen of the 25 IL-10À/À mice were female and nine were male animals; all control mice were female animals ( Table 1) .
T-cell populations in CELs from IL-10À/À and normal mice are shown in Fig. 1(A) . In both types of animals, TCRab T cells were present in higher proportions than TCRcd T cells, and CD8
+ T cells were present at a ratio of ;3-4:1 over CD4 + T cells (Fig. 1A) . The expression of four markers of T-cell activation, OX40, 4-1BB, CD69 and the inducible costimulatory (ICOS) molecule, was studied on IL-10À/À and normal CELs. Less than 5% of the T cells in either type of animal expressed OX40 or 4-1BB; CD69 was expressed on the majority (65.7-85.2%) of all T cells (data not shown). In contrast, in an IL-10À/À mouse that had gross colonic pathology with rectal prolapse, ICOS was expressed on a large proportion of CELs, which included >90% of the CD4 + cells as well as some non-CD4
+ cells (Fig. 1A) . By comparison, ICOS was expressed on few CELs from normal mice (Fig. 1A) . Similar patterns were observed in several CEL isolates from IL-10À/À and normal mice. These findings are consistent with reports that ICOS is up-regulated on human, rat and mouse colonic leukocytes during intestinal inflammation (23) (24) (25) .
Histopathological scoring is shown in Fig. 1 (B) for mice with grade 1 (Fig. 1Ba), grade 2 (Fig. 1Bb), grade 3 (Fig. 1Bc) , grade 4 ( Fig. 1Bd and f) and an IL-10À/À animal 20 weeks of age that had no histopathologic abnormalities (Fig. 1Be) . Histopathological scores (the average combined score from proximal and distal colon sections) for all 31 mice are shown in Fig. 2(A) . All IL-10À/À mice had histopathologic scores above or equal to grade 1, with the exception of one animal at 20 weeks of age that had no histopathologic abnormalities. Of the six control mice, four were negative for histopathology and two had histopathologic scores of 0.5 ( Fig. 2A) . The average histopathologic score for all animals in both groups is shown in Fig. 2(B) , which indicates a highly significant difference (P < 0.001) between IL-10À/À mice and control mice. There was no difference (P = 0.31) in histopathologic scores among IL-10À/À mice as a function of gender (Fig. 2C) . The percent purity of CEL isolates (percent CELs per total number of cells) is shown in Fig. 2(D) , which indicates essentially identical purities for both cell groups.
Numbers of CELs recovered from the colon of IL-10À/À and control mice are shown by age in Fig. 2(E) . Relative to the number of CELs from normal mice, all IL-10À/À mice had an increase in CELs with the exception of mice at 7 and 20 weeks of age (Fig. 2E) , the latter being IL-10À/À mice with minimal or no histopathology. Spearman correlation analysis comparing histopathologic scores with the number of CELs for all groups revealed a strong correlation between the number of CELs and intestinal pathology (r = 0.7666; P < 0.001) (Fig. 2F) .
CELs from the 25 IL-10À/À and six control mice were cultured for 24 h in serum-free medium in the absence of stimulation as described in Methods. Cell-free supernatants were collected and stored at À80°C until the time of analysis. As shown in Table 2 , 18 of the 23 analytes were present at high concentrations in culture supernatants from IL-10À/À mice relative to the activity of those analytes in control animals. There were trace or no detectable elevations in activities for five analytes in IL-10À/À mice ( Table 2) .
To determine the extent to which analyte levels correlated with the age of IL-10À/À mice, the data for each analyte were recorded graphically for the 18 analytes produced at high levels as listed in Table 2 . Among 17 of the 18 analytes (all but IL-17), analyte responses tended to be random with respect to animal age (Figs 3-7) . In general, no pattern emerged regarding the analyte level as a function of age of IL-10À/À mice throughout the period from 7 to 27 weeks. Moreover, among those 17 of 18 analytes, there were occasional animals with minimal or no elevation in analyte activity (Figs 3-7) . These findings are noteworthy because they indicate that even in the face of a broad spectrum of cytokine dysregulation, variations exist in degree to which individual cytokines are elevated, and they indicate that cytokine levels are not uniformly elevated. Only IL-17 was elevated for all IL-10À/À mice, with the exception of the two animals at 20 weeks of age that had histopathologic scores <1.0 (Fig. 4) .
As a second method to confirm the changes in analyte activities, Q-real-time PCR was done to quantify gene expression of three pro-inflammatory analytes: IFN-c, TNFa and IL-6. RNA was isolated from the ascending and descending colon of an IL-10À/À with grade 3 histopathology. Gene expression levels were compared with that of tissues from the ascending and descending colon of normal mice after normalizing each to GAPDH. Gene expression for all three cytokines were elevated in both the ascending and descending colon in IL-10À/À mice relative to normal mice (Fig. 7 , bottom panels), demonstrating that analyte activities were elevated at both the transcriptional and protein levels in IL-10À/À mice.
Analytes vary in the extent to which they correlate with intestinal pathology in IL-10À/À mice
To understand the relationship between analyte levels and colonic pathology, Spearman correlation analysis was done in which analyte values were compared with pathology scores for IL-10À/À and control mice. As shown in Fig. 8 , all 18 analytes listed in the top of Table 2 had positive correlations with pathology, indicating that each of those was active during the presence of intestinal disease. Correlation coefficients ranged from modest (r = 0.5876) for MIP-1a to high (r = 0.7765) for IL-12p40, with six analytes [IL-12p40, IL-6, granulocyte macrophage colony-stimulating factor (GM-CSF), IFN-c IL-13 and MCP-1] having especially strong correlations pathology scores (r > 0.700). These findings imply that colonic pathology in IL-10À/À mice is accompanied by the secretion of at least 18 cytokines as pathology is manifest across time.
IL-23p19 activity is not elevated in IL-10À/À mice relative to control animals
Because IL-23 was not part of our analyte panel, and because the IL-12p40 subunit is shared by IL-12 and IL-23, we examined the expression of IL-12p19 at both the protein and transcriptional levels. IL-23p19 levels were quantified by ELISA in the supernatant samples used for multiplex analyses and values were correlated with pathology scores. As shown in Fig. 9(A) , there was a lack of correlation (r = À0.0623) between pathology and IL-23p19 expression. This was further demonstrated by the lack of statistical significance in the difference of the total average values of IL-23p19 between IL-10À/À and normal mice (Fig. 9B) . Additionally, in an IL-10À/À mouse with grade 3 histopathology (Fig. 9C) , levels of IL-23p19 gene expression were similar between that animal and normal control mice at the transcriptional level as determined by conventional and Q-real-time PCR (Fig. 9D and E) .
Cross-correlation analysis of analyte activities reveals strong associations between analyte expression
To determine which analytes were operationally produced in common, Pearson correlation analysis was done by comparing all 18 analytes against each other, resulting in 324 combinations (Supplementary Table 1 , available at International Immunology Online). Of these, we examined in detail the six analytes (IL-12p40, IL-6, GM-CSF, IFN-c, IL-13 and MCP-1) having correlation coefficients of r > 0.7000 with regard to pathology as determined from the data in Fig. 9 . Results from this are shown in Table 3 , from which several patterns are evident. First, many of the analytes in this group have strong pro-inflammatory activities, e.g. IFN-c, TNFa, RANTES, IL-6, IL-1b, IL-12p40 and IL-12p70. Note that these are repeatedly present in combination with other similar analytes. Second, some analytes, which by themselves had only modest correlations with pathology (RANTES, MIP-1a, TNFa and granulocyte colony stimulating factor (G-CSF)), had strong associations with analytes having high correlations with pathology. Hence, the effect of combinations of those analytes may be to further exacerbate the disease process. A notable example of this is TNFa, which when scored individually had a modest correlation coefficient with pathology (r = 0.6340), but had very high cross-correlations with 12 analytes (r = 0.7071-0.9074) (Table 3) . Third, some analytes, e.g. IL-6 with TNFa, displayed extremely high cross-correlations with up to 10 additional analytes.
Discussion
This study was intended to gain a better understanding of the changes in immune response analytes that take place in the colonic epithelium during inflammatory conditions using the IL-10À/À animal model. Of the 23 analytes studied, 18 were elevated from an early age (7 weeks after birth). Four analytes showed no appreciable change; as expected, there was no IL-10 activity in IL-10À/À mice. Most analytes displayed no pattern as a function of age; however, IL-17 was elevated throughout the period of study from 7 to 27 weeks of age in all IL-10À/À mice with histopathologic scores >1.0. IL-17 activity was acquired precipitously by 7 weeks of age; colonic supernatants were negative for IL-17 in 3-to 6-week old IL-10À/À mice (data not shown). IL-17, a cytokine secreted by activated T cells (26) , has recently been shown to be produced by a specialized population of T cells referred to as T h 17 cells (27, 28) . T h 17 cells have been shown to play a role in the development of colonic pathology in IL-10À/À mice (8) . Although IL-17 ranked only ninth out of (r = 0.6592), it was produced at extremely high levels in all mice with pathology scores >1.0, thus demonstrating that intestinal pathology, whether mild or severe, is accompanied by the elaboration of IL-17.
IL-23 is largely considered to be a driving factor in the development of intestinal inflammation mediated by IL-17 (8, (29) (30) (31) (32) (33) . In those studies, blockade of IL-23 expression by antibody or gene knockout decreased disease scores, whereas treatment with recombinant IL-23 promoted colitis. The lack of correlation between IL-23p19 expression and colonic pathology in our study, at both the transcriptional and protein levels, was surprising; however, it may not be inconsistent with observations by others given that 24 of the 25 IL-10À/À mice in our study had pathology scores >1.0, indicating that those animals had intestinal disease at the time of analyses. Thus, it is possible that IL-23 is required for the initiation of pathology but not for the perpetuation of it. These are difficult issues to resolve in mice since, unlike human inflammatory bowel disease, there are no effective ways to monitor disease prospectively in living animals during therapy.
GM-CSF also displayed a high correlation with the presence of pathology. This is curious because GM-CSF has been used as a treatment of CD patients on the assumptions that the inflammatory response in CD owes to an imbalance of innate immunity resulting in excessive adaptive immune mechanisms (34) . Beneficial effects have been reported in CD patients treated with recombinant human GM-CSF or G-CSF (35, 36) . Whether the presence of GM-CSF in IL-10À/À mice reflects an attempt to balance innate versus adaptive immune responses remains to be determined.
The high association of IL-13 with colonic pathology (r = 0.7089) is similarly interesting. Although IL-13 has been shown to be over-expressed in patients with ulcerative colitis (37) , its role in disease is somewhat quixotic. Due to its capacity to constrain the inflammatory response (38) (39) (40) (41) and to promote tissue remodeling, fibrosis development and TGFb1 expression (42, 43) , IL-13 may be part of the host's overall attempt to rectify local tissue damage. Additionally, the presence of secreted IL-13 does not formally imply that it is available to intestinal tissues given that inflammatory factors can elicit expression of the IL-13Ra2 decoy receptor, a high-affinity receptor that markedly curtails the effects of IL-13 locally (44) and which is regulated in part by IL-10 itself (45). Cross-correlation studies in mice such as those detailed in Table 3 were particularly informative. It was evident, for example, that many pro-inflammatory cytokines are linked to disease expression. Thus, IL-12p40, IL-6, GM-CSF, IFN-c, IL-13 and MCP-1, all of which had high individual correlations with pathology, cross-correlated with other proinflammatory cytokines (e.g. IL-1a, IL-1b, IL-6, IL-12p40, IL-12p70, IFN-c, TNFa and RANTES). This was especially Table 2 .
Cytokine complexity in IL-10À/À mice 151 true for IL-12p40, IL-6 and IFN-c. Also striking was the relationship between TNFa and 12 other analytes that crosscorrelated with coefficients ranging from 0.7071 to 0.9074. The significance of that derives from the fact that in our study TNFa ranked only sixth out of 18 analytes with respect to pathology when viewed independently, yet it cross-correlated at a high level with a large number of other analytes. This finding may have bearing on the documented detrimental activity of TNFa in inflammatory bowel disease (46) , which may be due to adverse synergistic effects of TNFa working in combination with other cytokines. Additionally, the extraordinarily high cross-correlation between the expression of TNFa and IL-6 (r = 0.9074) implies a connection between those cytokines as disease progresses.
Expression of the T h 2 cytokine, IL-9, was elevated in 23 of 25 IL-10À/À mice. Although IL-9 had a modest correlation with pathology (r = 0.6615), due to its pleiotropic effects in immune regulation, IL-9 would be expected to have adverse effects in IL-10À/À mice resulting from anti-apoptotic activities on CD8+ T cells (47, 48) . This may have accounted for the expansion of colonic T cells as disease progressed (Fig.  2E and F) despite a lack of IL-2 and IL-4 activity ( Table 2) . IL-9 also is known to enhance Ig synthesis (49) and to augment the expression of eotaxin, MIP-1a and MCP-1 (50), three cytokines that were elevated in IL-10À/À mice in the present study.
Finally, the T h 2 cytokines, IL-2, IL-4 and IL-5, were unchanged in IL-10À/À mice, thus demonstrating that analyte dysregulation was by no means universal and confirming the T h 1 phenotype of the IL-10À/À mouse. This does not rule out the possibility that the lack of IL-2 activity across the range of ages in the 25 IL-10À/À mice might contribute to disease given that IL-2À/À mice also develop colitis (51) . In summary, the present study provides a detailed analysis of the nature of the cytokine dysregulatory process in the intestinal epithelium driven by IL-10 suppression. Perhaps most importantly, this study makes a strong case for the value in obtaining comprehensive data about the spectrum of immune response analytes in relationship to chronic inflammation of the intestine, and it suggests that such information will be valuable for planning immunotherapeutic protocols aimed at attenuating disease in ways that have not been approached hitherto.
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